- Investing Ideas
- Swiss Pharmaceuticals & Biotech Undervalued Dividend Payers
Swiss Pharmaceuticals & Biotech Undervalued Dividend Payers
Results
2
0 new
Companies available at a discount paying at least a 2% dividend yield.
2 companies
Roche Holding
Market Cap: CHF 252.5b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROP
CHF 315.60
7D
-0.8%
1Y
29.5%
Tecan Group
Market Cap: CHF 1.7b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 134.90
7D
-0.4%
1Y
-6.3%